Lamin A + C R453W Antibody (12A-2F5)

The lamin A gene is important in making nuclear structure and substructures for DNA replication appropriately in cells. The R453W mutation of LMNA, however, negates much of these normal characteristics, and instead causes the phenotypes of Emery-Dreifuss muscular dystrophy (EDMD). The mutation impairs myoblast formation and differentiation, and contributes to muscle wasting. R453W lamin changes the location of the H2K27me3 modified histone interaction with chromatin, which inactivates certain downstream genes. It also affects the normal lamin function of scaffolding substrates for the MEK-ERK pathway, and disrupts the structure of other binding sites. Thus, R453W seems to cause phenotypes of muscular dystrophy both through direct genetic impact, but also through epigenetic influence over normal scaffolding functionality related to DNA replication.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Human.

We have publications tested in 3 applications: ICC/IF, IP, WB.

Showing Publication 1 - 1 of 1.

Publication using NBP1-77401	Applications	Species
Roblek M, Schuchner S, Huber V, Ollram K, Vlcek-Vesely S, Foisner R, Wehnert M, Ogris E. Monoclonal antibodies specific for disease-associated point-mutants: lamin A/C R453W and R482W. PLoS One. 5(5):e10604. 2010-05-13 [PMID: 20498701] (WB, ICC/IF, IP, Human)	WB, ICC/IF, IP	Human

Images	Ratings	Applications	Species	Date	Details
Enlarge	4 reviewed by: Rajeshwari Bhat	WB	Human	06/01/2015	View Summary Application Western Blot Sample Tested HeLa cells transfected with lamin A/C R453W Species Human Lot A1

Array NBP1-77401

• Lamin A + C R453W Antibodies